2-(Butoxycarbonylamino)-3-phenylpropanoic acid | 75048-11-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(Butoxycarbonylamino)-3-phenylpropanoic acid
• CAS: 75048-11-2
• 化学式: C₁₄H₁₉NO₄
• 分子量: 265.309
• InChiKey: ZAUFWNBQTJVCMP-UHFFFAOYSA-N

物化性质

• 沸点：
  439.2±38.0 °C(Predicted)
• 密度：
  1.160±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  19
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  75.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(Butoxycarbonylamino)-3-phenylpropanoic acid 在 sodium hydroxide 、 N,N'-二环己基碳二亚胺 作用下， 以 乙醇 为溶剂， 生成 S4-L-Phe-L-His-OH
  参考文献：
  名称：

  Mechanism of enantioselective ester cleavage by histidine containing dipeptides at a micellar interface

  摘要：

  Chiral p-nitrophenyl esters derived from the amino acid phenylalanine are cleaved by histidine-containing dipeptides at a micellar interface. High enantioselectivities (up to k(L)/k(D) = 30.4 at 0-degrees-C) are observed. Both the substrates and the catalysts contain an alternating sequence of hydrophobic and hydrophilic groups. Due to the need for hydration of the hydrophilic groups, the hydrophobic groups cannot dissolve completely into the micellar hydrocarbon phase. The kinetic data suggest that the micellar interface is capable of discriminating between transition states that have different hydrophilic and hydrophobic properties. One of the diastereomeric transition states is characterized by a hydrogen bond between the amide CO group of the ester and an NH group of the histidine-containing dipeptide. Upon formation of this hydrogen bond these polar CO and NH groups lose their hydrophilicity which allows the transfer of the adjacent apolar groups to the micellar hydrocarbon phase. The other diastereomeric transition state cannot form this hydrogen bond and the hydrophobic groups remain hydrated. Consequently, the latter transition state is of higher energy. The kinetic data reveal that it is important to prevent steric hinderance between the reactants in order to allow the unhindered formation of the hydrogen bond.

  DOI：

  10.1021/jo00012a019
• 作为产物：
  描述：

  (4-methoxyphenyl)methyl 2-(butoxycarbonylamino)-3-phenylpropanoate 、 Tris(4-bromophenyl)amine radical cation 生成 2-(Butoxycarbonylamino)-3-phenylpropanoic acid
  参考文献：
  名称：

  DAPPERHELD, S.;STECKHAN, E., ANGEW. CHEM., 1982, 94, N 10, 785

  摘要：

  DOI：

文献信息

• [EN] GLYT2 MODULATORS<br/>[FR] MODULATEURS DU GLYT2
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2005044810A1

  公开（公告）日：2005-05-19

  α-, β-, and Ϝ-amino acid derivatives of formula I are disclosed as selective GlyT2 inhibitors for the treatment of central nervous system (CNS) conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain. Formula I

  公式I的α-, β-, 和 Ϝ-氨基酸衍生物被披露为选择性GlyT2抑制剂，用于治疗中枢神经系统（CNS）疾病，如肌肉痉挛、耳鸣、癫痫和神经痛。
• [EN] HETEROARYL BTK INHIBITORS<br/>[FR] INHIBITEURS HÉTÉROARYLES DE BTK
  申请人：BIOGEN IDEC INC

  公开号：WO2011029043A1

  公开（公告）日：2011-03-10

  The present invention provides compounds useful as inhibitors of Btk, compositions thereof, and methods of using the same.

  本发明提供了作为Btk抑制剂有用的化合物，其组成物以及使用这些化合物的方法。
• [EN] PREPARATION OF ß-PHENYL-ISOSERINE DERIVATIVES<br/>[FR] PRÉPARATION DE DÉRIVÉS DE ?-PHÉNYL-ISOSÉRINE
  申请人：ORGANOCLICK AKTIEBOLAG

  公开号：WO2010024762A1

  公开（公告）日：2010-03-04

  A process for stereoselective synthesis of a β-phenylisoserine comprises reacting a carbonyl imine R-C=N-CO-OR1 with a protected α- oxyaldehyde X1O-CH2CHO in the presence of a chiral amine catalyst and oxidizing aldehyde so obtained.

  一种立体选择性合成β-苯基异丝氨酸的方法，包括在手性胺催化剂的存在下，将羰基亚胺R-C=N-CO-OR1与保护的α-氧代醛X1O-CH2CHO反应，并氧化获得的醛。
• [EN] GLYCINE B ANTAGONISTS<br/>[FR] ANTAGONISTES DE LA GLYCINE B
  申请人：MERZ PHARMA GMBH & CO KGAA

  公开号：WO2012164085A1

  公开（公告）日：2012-12-06

  The invention relates to 2(1H)-quinolinone derivatives of formula (I) as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.

  该发明涉及公式（I）的2（1H）-喹啉酮衍生物及其药用可接受的盐。该发明还涉及一种制备此类化合物的方法。该发明的化合物是甘氨酸B拮抗剂，因此对于控制和预防各种疾病，包括神经系统疾病，具有用途。
• Novel melanocortin receptor agonists and antagonists
  申请人：——

  公开号：US20030195212A1

  公开（公告）日：2003-10-16

  The present invention relates to novel aromatic amines of general formula (I) and to the use of these amines for the treatment of obesity, anorexia, inflammation, mental disorders an other diseases associated with the melanocortin receptors or related systems, e.g. the melanocyte stimulating hormones.

  本发明涉及一种新型芳香胺的一般化学式（I），以及利用这些胺治疗肥胖、厌食、炎症、精神障碍和其他与黑素皮质激素受体或相关系统有关的疾病的用途。